Exploring Two ASX Movers: What’s Driving Momentum in Mineral Resources and ResMed?

3 min read | April 15, 2025 12:41 PM AEST | By Team Kalkine Media

Google News:

Exploring Two ASX Movers: What’s Driving Momentum in Mineral Resources and ResMed? — Image source: shutterstock

Recent News

ASX Industrial Stocks Outlook ASX 200 and Logistics Trends

Boom, Bust and Back Again: Mastering the Mining Cycle in 2026

Iron, Copper and Competition: Which Mining Giant Stands Out in 2026?

The Metal of Everything: Why Copper Is Becoming Mining’s Biggest Prize

Make Kalkine Media
My Trusted Source

Highlights

Mineral Resources shares dip significantly in 2025

ResMed tracks strong rebound from 52-week low

Key insights into dividend trends and business outlook

Two Australian-listed companies are drawing attention for very different reasons. Mineral Resources (MIN) has seen a steep decline in its share price since the start of 2025, while ResMed (RMD) is showing signs of strength, tracking well above its recent 52-week low. Here's a closer look at what’s been unfolding for these two ASX-listed businesses.

Mineral Resources (ASX:MIN): A Closer Look at the Slide

Mineral Resources is a diversified mining and services company primarily operating in Western Australia. Its core operations span lithium and iron ore extraction, critical commodities that feed into global demand for batteries and steel, respectively.

In addition to its resource extraction business, Mineral Resources also operates CSI Mining Services, offering infrastructure and operational support to mining operations across WA, Queensland, and the Northern Territory. What makes the company unique is its focus on keeping engineering and construction capabilities in-house. This approach offers more agility and control when scaling projects or adapting to market shifts.

Despite these strengths, shares in Mineral Resources have declined over 48% in 2025. One lens through which this drop can be analyzed is dividend yield. Currently sitting around 1.11%, the dividend yield is well below its five-year average of 2.40%. This divergence could suggest either falling dividend payouts or a significant rise in share price—however, in this case, it's a reflection of reduced dividends, as the latest annual payout is lower than the three-year average.

ResMed (ASX:RMD): Building from the Bottom

Founded in 1989 and now headquartered in the US, ResMed is a global leader in medical devices and digital health solutions for sleep and respiratory care. The company designs and sells CPAP machines that help manage obstructive sleep apnea (OSA) and other ventilation support devices.

With operations in over 140 countries and a workforce of more than 10,000, ResMed also operates a growing Software as a Service (SaaS) segment. This side of the business offers cloud-based solutions that streamline logistics, documentation, and compliance for home medical equipment providers. It’s a strategic move that aligns with broader trends in digital healthcare and at-home treatment models.

ResMed shares are currently 24.3% above their 52-week low, signaling growing investor interest. As the company continues to innovate in both hardware and SaaS offerings, it remains a noteworthy player in global healthcare infrastructure.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.